Total Raised

$150.1M

Investors Count

11

Truvian Sciences Funding, Truvian Sciences Valuation & Truvian Sciences Revenue

6 Fundings

Truvian Sciences's latest funding round was a Series C for $105M on February 24, 2021.

Date

Round

Amount

Investors

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Revenue

Sources

2/24/2021

Series C

$105M

0

FY undefined

16

4/28/2020

Loan

$99M

0

FY undefined

0

11/20/2019

Series B

$99M

0

FY undefined

10

1/1/2018

Series A

$99M

0

FY undefined

0

10/19/2015

Seed VC

$99M

0

FY undefined

10

Date

2/24/2021

4/28/2020

11/20/2019

1/1/2018

10/19/2015

Round

Series C

Loan

Series B

Series A

Seed VC

Amount

$105M

$99M

$99M

$99M

$99M

Investors

Valuation

Revenue

0

FY undefined

0

FY undefined

0

FY undefined

0

FY undefined

0

FY undefined

Sources

16

0

10

0

10

Truvian Sciences Investors

11 Investors

Truvian Sciences has 11 investors. DNS Capital invested in Truvian Sciences's Series C funding round.

First funding

Last Funding

Investor

Rounds

Board Seats

Type

Location

11/20/2019

2/24/2021

2
Series B, Series C (2021)

Holding Company

Illinois

11/20/2019

2/24/2021

2
Series B, Series C (2021)

Venture Capital

California

2/24/2021

2/24/2021

1
Series C

Venture Capital

California

00/00/0000

00/00/0000

Wittington Ventures

Subscribe to see more

Holding Company

Canada

00/00/0000

00/00/0000

TYH Ventures

Subscribe to see more

Venture Capital

California

First funding

11/20/2019

11/20/2019

2/24/2021

00/00/0000

00/00/0000

Last Funding

2/24/2021

2/24/2021

2/24/2021

00/00/0000

00/00/0000

Investor

Wittington Ventures

TYH Ventures

Rounds

2
Series B, Series C (2021)
2
Series B, Series C (2021)
1
Series C

Subscribe to see more

Subscribe to see more

Board Seats

Type

Holding Company

Venture Capital

Venture Capital

Holding Company

Venture Capital

Location

Illinois

California

California

Canada

California

You May Also Like

S
Sight Diagnostics

Sight Diagnostics provides affordable and accurate diagnostics in a compact platform designed for use in qualified labs in low volume settings. Its proprietary machine-vision based technology provides the capability to perform multiple tests on a single, easy-to-operate platform.

BD Logo
BD

BD is a medical technology company that manufactures and sells a broad range of supplies, devices, and systems for use by healthcare professionals, medical research institutions, industry, and the general public.

Visby Medical Logo
Visby Medical

Visby Medical is transforming the order of diagnosis and treatment for infectious diseases so clinicians can test, talk with, and treat the patient in a single visit. The company’s technology development program culminated in an instrument-free, single-use PCR platform that rapidly tests for serious infections. Originally developed for sexually transmitted infections, the Company’s FDA-cleared, CLIA-waived Sexual Health Click Test for women returns accurate results within 28 minutes. Visby Medical technology also offers the Visby Medical COVID-19 Test, and its robust pipeline includes tests for other infectious diseases. It was founded in 2015 and is based in San Jose, California.

D
DiaSorin

DiaSorin is a multinational biotechnology company that produces and markets in vitro diagnostics reagent kits used in immunodiagnostics and molecular diagnostics. It is based in Saluggia, Italy.

Weavr Health Logo
Weavr Health

Weavr Health is dedicated to connecting people to health by simplifying sample collection and processing for healthcare.The Velvet device is designed so anyone, anywhere can easily collect high-quality samples without a phlebotomist. The Velvet device offers a smooth experience of blood self-collection for patients. It leverages a similar experience to traditional glucose testing, which >25% of people have experienced. Each device arrives with all that is needed to collect, package and ship quality samples to the lab for a convenient experience.

MeMed Logo
MeMed

MeMed is a med-tech and bio-convergence firm that researches, develops, and commercializes diagnostic host immune response testing methods that address complex clinical dilemmas and improve patient outcomes.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.